Xia L, Shen W, Ritacca F, Mitri A, Madlensky L, Berk T, Cohen Z, Gallinger S, Bapat B
Department of Pathology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.
Cancer Res. 1996 May 15;56(10):2289-92.
Germline mutations of the hMSH2 gene are responsible for many cases of hereditary nonpolyposis colorectal cancer. While screening for hMSH2 gene mutations in hereditary nonpolyposis colorectal cancer kindreds, we observed that a previously reported germline mutation is in fact a common, alternatively spliced variant in the population. Using RT-PCR and the protein truncation test, the hMSH2 exon 13 deletion variant was found in more than 90% of individuals. The exon 13 deletion transcript was only present in lymphocyte RNA, no abnormalities were detected in genomic DNA flanking exon 13, and the deletion transcript is apparently not translated. These findings highlight further that caution should be exercised in providing genetic risk assessment on the basis of currently used germline mutation detection strategies.
hMSH2基因的种系突变是许多遗传性非息肉病性结直肠癌病例的病因。在对遗传性非息肉病性结直肠癌家系进行hMSH2基因突变筛查时,我们观察到一个先前报道的种系突变实际上是人群中一种常见的可变剪接变体。通过逆转录聚合酶链反应(RT-PCR)和蛋白质截短试验,在90%以上的个体中发现了hMSH2外显子13缺失变体。外显子13缺失转录本仅存在于淋巴细胞RNA中,外显子13侧翼的基因组DNA未检测到异常,且该缺失转录本显然未被翻译。这些发现进一步强调,在基于目前使用的种系突变检测策略进行遗传风险评估时应谨慎行事。